Related Experiment Videos
Endemic brucellar epididymo-orchitis: a 10-year experience
Athanasios G Papatsoris1, Filitsa A Mpadra, Michalis V Karamouzis
1Department of Urology, St Andrews Patras Regional Hospital, Greece. agpapatsoris@hotmail.com
Summary
Brucella melitensis-induced epididymo-orchitis presents unique clinical features distinct from non-specific cases. Early detection and prompt anti-Brucella medication are crucial for effective treatment and improved outcomes in endemic areas.
Area of Science:
- Infectious Diseases
- Urology
- Epidemiology
Background:
- Epididymo-orchitis is a common urological condition with diverse etiologies.
- Brucella melitensis infection can cause epididymo-orchitis, presenting distinct clinical characteristics compared to non-specific cases.
- Accurate differentiation is critical for appropriate management and patient outcomes.
Purpose of the Study:
- To delineate the epidemiologic, clinical, and laboratory features of Brucella melitensis-induced epididymo-orchitis.
- To compare these features with non-specific epididymo-orchitis.
- To evaluate treatment and outcomes for Brucella melitensis-induced epididymo-orchitis.
Main Methods:
- Retrospective review of 17 patients with Brucella melitensis epididymo-orchitis.
- Comparison with 141 cases of non-Brucella epididymo-orchitis.
- Data collected from a tertiary hospital in southwestern Greece (1991-2000); statistical analysis using chi-square test.
Main Results:
- Brucella melitensis epididymo-orchitis showed higher occupational risk, seasonal pattern, gradual onset, longer duration, undulatory fever, less leukocytosis, and milder local inflammation.
- Oral doxycycline and rifampicin for 6 weeks proved effective.
- No relapses or significant side effects were observed during follow-up.
Conclusions:
- Brucella melitensis-induced epididymo-orchitis is a significant clinical issue in endemic regions.
- Early diagnosis and appropriate anti-Brucella treatment are essential.
- Clinicians should consider brucellosis in epididymo-orchitis cases and initiate treatment promptly, even before serological confirmation.